The overactivity of glycolytic pathways, particularly through the stabilization of hypoxia-inducible factor 1-alpha (HIF-1α) under normoxic conditions, promotes survival signals and inhibits cell death pathways, thereby contributing to leukemia progression and chemotherapy resistance [95,96]. Here, HIF1A is linked to leukemia.